Dorsal injections for treating trigger finger pain
Trigger Finger Corticosteroid Injection Pain: Palmar Injection Versus Dorsal Intrasynovial (Transthecal) Injection
This study is testing whether giving corticosteroid injections from the back of the hand can help adults with trigger finger feel less pain compared to the traditional method from the palm.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT06476977 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of administering corticosteroid injections for trigger finger from the dorsal side of the hand instead of the traditional palmar approach. Trigger finger is characterized by pain and locking of the fingers due to tendon inflammation, and the dorsal approach aims to reduce the pain associated with the injection. Participants will receive either a dorsal or palmar injection to compare pain levels and treatment outcomes. The study focuses on adults diagnosed with trigger finger who are opting for corticosteroid injections.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older diagnosed with trigger finger who are seeking corticosteroid injections for management.
Not a fit: Patients who have previously undergone surgery or multiple corticosteroid injections for the same digit may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the pain associated with corticosteroid injections for trigger finger, improving patient comfort and treatment adherence.
How similar studies have performed: Previous studies have explored dorsal injection techniques, but this specific approach is being evaluated for its effectiveness in reducing pain during corticosteroid administration.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be 18 years of age or older * Have a diagnosis of trigger finger (can be any of the 5 digits) * Opting to receive a CSI for their triggering finger Exclusion Criteria: * Decline to obtain a CSI for trigger finger management * Receiving multiple CSI for trigger finger management at the appointment * Past CSI and/or surgery to the digit involved * Unable to communicate in English
Where this trial is running
Toronto, Ontario
- University Health Network - Toronto Western Hospital — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Kevin Zuo, MD, MASc — University Health Network, Toronto
- Study coordinator: Kevin Zuo, MD, MASc
- Email: kevin.zuo@uhn.ca
- Phone: 416-603-5802
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.